Topic Highlight
Copyright ©2007 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Nov 28, 2007; 13(44): 5805-5812
Published online Nov 28, 2007. doi: 10.3748/wjg.v13.i44.5805
Rectal cancer treatment: Improving the picture
Juan A Diaz-Gonzalez, Leire Arbea, Javier Aristu
Juan A Diaz-Gonzalez, Leire Arbea, Javier Aristu, Department of Oncology, Clinica Universitaria, Universtity of Navarra, Pamplona 31080, Spain
Author contributions: All authors contributed equally to the work.
Correspondence to: Juan A Diaz-Gonzalez, Department of Oncology, Clinica Universitaria, Universtity of Navarra, Avda. Pio XII, 36, Pamplona 31080, Spain. jadiaz@unav.es
Telephone: +34-948-255400 Fax: +34-948-255500
Received: September 30, 2006
Revised: December 12, 2006
Accepted: September 15, 2007
Published online: November 28, 2007
Abstract

Multidisciplinary approach for rectal cancer treatment is currently well defined. Nevertheless, new and promising advances are enriching the portrait. Since the US NIH Consensus in the early 90’s some new characters have been added. A bird’s-eye view along the last decade shows the main milestones in the development of rectal cancer treatment protocols. New drugs, in combination with radiotherapy are being tested to increase response and tumor control outcomes. However, therapeutic intensity is often associated with toxicity. Thus, innovative strategies are needed to create a better-balanced therapeutic ratio. Molecular targeted therapies and improved technology for delivering radiotherapy respond to the need for accuracy and precision in rectal cancer treatment.

Keywords: Rectal cancer, Chemoradiotherapy, Intensity-modulated radiation therapy, Molecular targeted therapy